Amicus Therapeutics Inc (NASDAQ:FOLD)

8.76
Delayed Data
As of Feb 27
 -0.03 / -0.34%
Today’s Change
1.77
Today|||52-Week Range
9.63
+5.29%
Year-to-Date
No recent news for Amicus Therapeutics Inc.

Today’s Trading

Previous close8.79
Today’s open8.77
Day’s range8.41 - 8.77
Volume809,751
Average volume (3 months)1,437,249
Market cap$837.1M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-8.41%
Earnings growth (this year)+24.14%
Earnings growth (next 5 years)--
Revenue growth (last year)-98.03%
P/E ratioNM
Price/Sales332.02
Price/Book11.87

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-0.49-1.87%
TXMDTherapeuticsMD Inc-0.27-5.06%
SGNTSagent Pharmaceutica...-1.16-4.09%
EPZMEpizyme Inc-0.08-0.34%
Data as of 4:04pm ET, 02/27/2015

Financials

Last reporting dateFebruary 16, 2015
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$363.0K
Annual profit (last year)-$59.6M
Net profit margin-16,427.82%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account